VENANZI, Franco
 Distribuzione geografica
Continente #
NA - Nord America 3.578
EU - Europa 1.652
AS - Asia 1.197
SA - Sud America 102
Continente sconosciuto - Info sul continente non disponibili 64
AF - Africa 50
OC - Oceania 6
Totale 6.649
Nazione #
US - Stati Uniti d'America 3.464
CN - Cina 451
RU - Federazione Russa 395
SG - Singapore 366
PL - Polonia 287
IT - Italia 254
DE - Germania 196
GB - Regno Unito 115
VN - Vietnam 105
CA - Canada 93
HK - Hong Kong 93
SE - Svezia 93
UA - Ucraina 89
BR - Brasile 84
FR - Francia 75
FI - Finlandia 62
TR - Turchia 35
ZA - Sudafrica 35
IN - India 34
KR - Corea 30
BD - Bangladesh 20
JP - Giappone 19
NL - Olanda 15
BE - Belgio 13
IE - Irlanda 11
MX - Messico 11
ES - Italia 10
EU - Europa 10
AR - Argentina 8
GR - Grecia 6
LT - Lituania 6
TH - Thailandia 6
RO - Romania 5
CO - Colombia 4
HU - Ungheria 4
IQ - Iraq 4
IR - Iran 4
MY - Malesia 4
NZ - Nuova Zelanda 4
PH - Filippine 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
IL - Israele 3
KE - Kenya 3
TW - Taiwan 3
AU - Australia 2
CH - Svizzera 2
DK - Danimarca 2
EC - Ecuador 2
EE - Estonia 2
EG - Egitto 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
JM - Giamaica 2
LK - Sri Lanka 2
MA - Marocco 2
NG - Nigeria 2
PK - Pakistan 2
TN - Tunisia 2
AZ - Azerbaigian 1
BF - Burkina Faso 1
BG - Bulgaria 1
BO - Bolivia 1
CD - Congo 1
CG - Congo 1
CL - Cile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ID - Indonesia 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
UZ - Uzbekistan 1
Totale 6.595
Città #
Ashburn 283
Warsaw 273
Woodbridge 249
Fairfield 233
Ann Arbor 217
Jacksonville 217
Singapore 198
Houston 183
San Jose 160
Chandler 157
Wilmington 124
Council Bluffs 118
Seattle 115
New York 103
Boardman 94
Cambridge 92
Hong Kong 92
Dallas 77
Beijing 75
Nanjing 67
The Dalles 55
Toronto 54
Dearborn 50
Los Angeles 48
San Mateo 37
Ho Chi Minh City 33
Johannesburg 33
Chicago 31
Helsinki 30
Nanchang 29
Rome 29
Columbus 28
Buffalo 27
Lawrence 27
Princeton 27
Seoul 27
Tongling 26
Camerino 25
Ogden 23
Istanbul 22
Hanoi 21
Lauterbourg 21
Moscow 21
Lachine 20
London 20
Munich 19
Santa Clara 17
Shanghai 17
Shenyang 17
Dong Ket 15
Düsseldorf 15
Changsha 14
Kunming 14
Tokyo 14
Centro 13
São Paulo 13
Brussels 12
Frankfurt am Main 12
Milan 12
Orem 12
San Diego 12
Chennai 11
Denver 11
Dublin 11
Kraków 11
St Louis 11
Stockholm 11
Phoenix 10
Wuhan 10
Kochi 9
Tianjin 9
Atlanta 8
Hefei 8
Jiaxing 8
Verona 8
Catania 7
Philadelphia 7
Ancona 6
Auburn Hills 6
Boston 6
Detroit 6
Guangzhou 6
Haiphong 6
Hebei 6
Jinan 6
Leawood 6
Poplar 6
Redwood City 6
Turku 6
Ankara 5
Augusta 5
Belo Horizonte 5
Bologna 5
Brooklyn 5
Fuzhou 5
Macerata 5
Amsterdam 4
Auckland 4
Bexley 4
Charlotte 4
Totale 4.392
Nome #
Administration of DNA Plasmid Coding Protein Aggregating Domain Induces Inflammatory Bone Loss. 481
Glutamicibacter creatinolyticus strain LGCM 259 chromosome, complete genome 320
Autoantibody to p185erbB2/neu oncoprotein by vaccination with xenogenic DNA 291
null 288
Antibody and CD8+ T Cell Responses against HER2/neu Required for Tumor Eradication after DNA Immunization with a Flt-3 Ligand Fusion Vaccine. 274
Plasmids encoding protein aggregation domains act as molecular adjuvants for DNA vaccines 262
Genetic immunization against neu /erbB2 transgenic breast cancer 259
Immunorecognition of ring skeleton of taxanes by chicken egg yolk antibodies 258
Effect of phospholipid membranes on the specific and nonspecific transcription systems in vitro 251
Tumor endothelial marker 8 enhances tumor immunity in conjunction with immunization against differentiation Ag 250
Polynucleotide Immunogenic Agents. 238
Altered Expression of FAS System Is Related to Adverse Clinical Outcome in Stage I-II Breast Cancer Patients Treated with Adjuvant Anthracycline-Based Chemotherapy. 234
Pilot study of p62 DNA vaccine in dogs with mammary tumors 233
Co-Expression of Flt-3 Ligand Gene Ablates Tumor Immunity Elicited by HER-2/neu DNA Vaccine in Transgenic Mice 228
Broad-spectrum Anti-tumor and Anti-metastatic DNA Vaccine Based on p62- encoding Vector 225
Recombinant DNA Technology for Melanoma Immunotherapy: Anti-Id DNA Vaccines Targeting High Molecular Weight Melanoma-Associated Antigen 225
Unfaithful association of FCGR2B genetic polymorphisms with susceptibility to SLE. 221
Nucleic acids in mummified plant seeds: biochemistry and molecular genetics of pre-Columbian maize. 219
Tumor endothelial marker 8 expression levels in dendritic cell-based cancer vaccines are related to clinical outcome 219
Binding of feline immunodeficency viral gag-p24 polypepdide to non immune Igs 204
neu/HER2 cDNA Vaccination and pregnancy lost. 204
Molecular stability of DNA typing short tandem repeats in the mammary tree of breast cancer patients. 203
Altered expression of Fas system is related to adverse clinical outcome in stage I-II breast cancer patients with adjuvant anthracycline -based chemotherapy 187
Mummy RNA lasts longer. 185
Methods and compositions relating to p62 for the treatment and prophylaxis of cancer 185
Long-term immunological effects of thymectomy in patients with myastenia gravis. 174
Methods and compositions relating to p62/sqstm for the treatment and prevention of inflammation-associated diseases 171
Plasmid DNA-coding p62 as a bone effective anti-inflammatory/anabolic agent 121
The complete genome sequencing of G. creatinolyticus LGCM 259. BioProject: PRJNA507728, BioSample: SAMN10502625, Assembly: GCF_006094275.1, NCBI RefSeq sequence NZ_CP034412.1. LOCUS NZ_CP034412 3309128 bp DNA circular. 39
Totale 6.649
Categoria #
all - tutte 22.491
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.491


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022192 0 0 0 18 16 18 10 20 22 38 19 31
2022/2023410 47 12 35 63 41 51 2 20 58 29 30 22
2023/2024351 41 21 15 6 15 81 11 8 27 8 12 106
2024/20251.047 32 18 68 37 42 48 152 258 115 79 58 140
2025/20261.440 88 76 148 238 166 129 211 97 64 94 78 51
2026/2027309 90 38 94 87 0 0 0 0 0 0 0 0
Totale 6.649